Carfilzomib is a novel proteasome inhibitor employed in the battle against cancer. This drug functions by hindering the activity of the proteasome, a cellular complex responsible for the degradation of proteins. By inhibiting this mechanism, carfilzomib leads the buildup of damaged or abnormal proteins, ultimately causing cell death. Carfilzomib ex

Tepotinib, also known as {MSC2156119|the developmental compound|this agent), represents a novel advance in the targeting of lung condition, particularly in patients harboring MET changes. This targeted tyrosine kinase blocker|TKI demonstrates substantial activity against cancer progression in preclinical research and first human assessments. Its me

Matrine is a naturally occurring alkaloid primarily synthesized from the roots of the *Sophora* genus, particularly *Sophora flavescens*. Extensive studies have investigated its therapeutic properties, revealing a range of potential benefits. Matrine has demonstrated cytotoxic effects, making it attractive as a potential therapy for various disease